Terminal Access

Unlimited access to the most powerful analytical tools in finance.

Bloomberg Fair Value
20M Securities
50Y History
10Y Estimates
8.000+ News Daily
Subscribe for $2
Overview
Profile

Dimed SA Distribuidora de Medicamentos stock

PNVL3.SA
BRPNVLACNOR9

Price

8.17 BRL
Today +/-
-0.00 BRL
Today %
-0.37 %

Dimed SA Distribuidora de Medicamentos stock price

BRL
%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Dimed SA Distribuidora de Medicamentos stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Dimed SA Distribuidora de Medicamentos stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Dimed SA Distribuidora de Medicamentos stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Dimed SA Distribuidora de Medicamentos's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Dimed SA Distribuidora de Medicamentos Stock Price History

DateDimed SA Distribuidora de Medicamentos Price
3/9/20258.17 BRL
3/6/20258.20 BRL
3/5/20258.10 BRL
3/4/20257.95 BRL
2/27/20258.20 BRL
2/26/20258.02 BRL
2/25/20257.89 BRL
2/24/20258.03 BRL
2/23/20258.01 BRL
2/20/20258.18 BRL
2/19/20258.17 BRL
2/18/20258.14 BRL
2/17/20258.33 BRL
2/16/20258.43 BRL
2/13/20258.20 BRL
2/12/20258.00 BRL
2/11/20257.94 BRL
2/10/20258.20 BRL

Dimed SA Distribuidora de Medicamentos Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Dimed SA Distribuidora de Medicamentos, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Dimed SA Distribuidora de Medicamentos from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Dimed SA Distribuidora de Medicamentos’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Dimed SA Distribuidora de Medicamentos. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Dimed SA Distribuidora de Medicamentos’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Dimed SA Distribuidora de Medicamentos’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Dimed SA Distribuidora de Medicamentos’s growth potential.

Dimed SA Distribuidora de Medicamentos Revenue, EBIT and net profit per share

DateDimed SA Distribuidora de Medicamentos RevenueDimed SA Distribuidora de Medicamentos EBITDimed SA Distribuidora de Medicamentos Net Income
2028e8.12 B BRL410.04 M BRL0 BRL
2027e7.52 B BRL0 BRL0 BRL
2026e6.93 B BRL314.15 M BRL219.95 M BRL
2025e6.15 B BRL250.29 M BRL179.67 M BRL
2024e5.52 B BRL189.86 M BRL136.3 M BRL
20234.46 B BRL161.89 M BRL92.91 M BRL
20223.99 B BRL133.87 M BRL86.35 M BRL
20213.23 B BRL95.4 M BRL79.43 M BRL
20202.82 B BRL87.92 M BRL56.15 M BRL
20192.72 B BRL121.61 M BRL76.76 M BRL
20182.43 B BRL114.04 M BRL74.98 M BRL
20172.26 B BRL93.03 M BRL59.8 M BRL
20162.13 B BRL110.29 M BRL53.06 M BRL
20151.99 B BRL92.68 M BRL45.27 M BRL
20141.89 B BRL88.25 M BRL49.36 M BRL
20131.74 B BRL85 M BRL56.1 M BRL
20121.52 B BRL69.1 M BRL47.1 M BRL
20111.35 B BRL57.1 M BRL37.4 M BRL
20101.19 B BRL53.3 M BRL30.8 M BRL
20091.07 B BRL39.7 M BRL29.7 M BRL
2008933.2 M BRL10.2 M BRL9.7 M BRL
2007832.8 M BRL17.1 M BRL14.2 M BRL
2006733.5 M BRL18.4 M BRL14.4 M BRL
2005647.5 M BRL14.8 M BRL12.8 M BRL
2004579.6 M BRL13.2 M BRL11.5 M BRL

Dimed SA Distribuidora de Medicamentos Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B BRL)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B BRL)NET INCOME (M BRL)NET INCOME GROWTH (%)DIV. (BRL)DIV. GROWTH (%)SHARES (M)DOCUMENTS
199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e2027e2028e
0.380.460.480.450.440.370.440.480.530.580.650.730.830.931.071.191.351.521.741.891.992.132.262.432.722.823.233.994.465.526.156.937.528.12
-21.375.00-7.25-2.46-14.4218.458.1311.068.8311.7413.2913.5112.1415.1110.8013.0313.3114.178.455.257.156.117.7112.013.4914.4023.7211.8023.7411.4712.568.627.92
17.1516.5216.3618.3019.6817.6518.7418.7921.0521.4219.7818.8318.3917.1521.5121.5121.5622.4421.9522.2022.7124.4429.4529.4029.6629.1930.6431.1330.8724.9522.3819.8818.3016.96
0.070.080.080.080.090.070.080.090.110.120.130.140.150.160.230.260.290.340.380.420.450.520.670.720.810.820.991.241.3800000
61411873761011121414929303747564945535974765679869213617921900
-133.33-21.43-27.27-12.50-57.14133.33-14.2966.6710.009.0916.67--35.71222.223.4523.3327.0319.15-12.50-8.1617.7811.3225.422.70-26.3241.078.866.9847.8331.6222.35--
----------------------------------
----------------------------------
3.54.55.2554.94.94.84.84.74.74.74.64.64.64.64.64.64.6136.81136.77136.77136.67136.24135.76151.32149.59149.15149.7200000
----------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Dimed SA Distribuidora de Medicamentos Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Dimed SA Distribuidora de Medicamentos is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M BRL)RECEIVABLES (M BRL)OTHER REC. (M BRL)INVENTORIES (M BRL)OTHER CURRENT LIAB. (M BRL)CURRENT ASSETS (B BRL)TANGIBLE ASSETS (B BRL)LONG-T. INVEST. (M BRL)LONG-T. REC. (M BRL)INTANGIBLE ASSETS (M BRL)GOODWILL (M BRL)OTHER NON-CURRENT ASSETS (M BRL)NON-CURRENT ASSETS (B BRL)TOTAL ASSETS (B BRL)LIABILITIESCOMMON STOCK (M BRL)ADDITIONAL PAID-IN CAPITAL (M BRL)RETAINED EARNINGS (M BRL)OTHER EQUITY (M BRL)UNREAL. GAINS/LOSSES (M BRL)EQUITY (B BRL)LIABILITIES (M BRL)PROVISIONS (M BRL)OTHER SHORT-TERM LIAB. (M BRL)SHORT-TERM DEBTS (k BRL)LONG-TERM DEBT PORTION (M BRL)SHORT-TERM REC. (B BRL)LONG-T. LIAB. (M BRL)DEFERRED TAXES (M BRL)OTHER LIAB. (M BRL)LONG-T. LIABILITIES (M BRL)DEBT (B BRL)TOTAL CAPITAL (B BRL)
19951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                                         
12.18.69.316.413.585.523.525.817.319.623.518.920.341.822.336.328.218.924.771722.3458.7939.1471.44435.81209.65157.36245.39
24.936.741.746.642.236.735.240.346.253.968.268.175.581.688.8108.7118.2141.2133.4185.1188.87182.43194.24198.86276.52285.75324.62399.17452.01
6.80.51.50.81.919.324.72.31.71.210.29.75.94.10.97.614.821.420.425.2526.1828.6453.3264.3474.1580.12121.78105.48142.13
33.451.255.948.26252.959.953.872.882.888.6102.2116.9121.5146.3175.9192.1210.4248.4271.58307.84357.04398.68424.46429.03574.82739.04896.54999.41
0003.34.52.32.622.323.73.14.76.66.2000000000.3300001.12
0.080.10.110.120.120.120.130.120.150.160.190.210.220.230.280.310.360.40.420.510.540.590.710.730.851.381.41.561.84
0.010.010.020.020.020.020.020.020.020.020.020.020.020.030.040.050.060.080.160.190.190.20.210.230.550.720.871.031.08
0.511.51.41.25.45.90.30.30.30.30.30.30.10.10000.30.340.280.280.280.280.280.280.0100
0000000000000.40.30.50.70.913.22.432.021.721.482.213.215.867.99.6312.37
00000000000004.14.74.86.86.89.18.6911.3914.820.724.9833.0945.8759.9476.7483.32
00000000000000000000000000000
1.40.811.81.21.61.91.62.13.46.97.69.57.57.310.810.311.511.112.7112.4912.8214.3211.3520.9142.1744.0353.7860.93
0.020.020.020.020.020.030.030.020.020.020.030.030.030.040.050.060.080.10.180.210.220.230.250.270.610.820.991.171.24
0.090.110.130.140.150.150.160.150.170.180.220.230.250.280.330.380.440.50.60.720.760.820.9511.462.192.382.733.08
                                                         
354551.867.373788084879298.5106.5116124129.5148170195227260295325360385410897.55903.55928.55955.67
00000000000000000000000000000
10.53.54.34.63.22.22.21.71.72.12.22.31.91.72.65.74.36.720.319.5450.4756.7867.3688.32114.18113.09176.05214.75246.33
7.114.415.35.24.61.83.92.95.678.29.39.25.32020.325.632.230.232.84000000000
00000000000000000000000000000
0.050.060.070.080.080.080.090.090.090.10.110.120.130.130.150.170.20.230.280.310.350.380.430.470.521.011.081.141.2
22.933.236.836.545.445.751.637.855.855.873.278.387.283.2108.3129.1151.8151.5160184.29209.76250.24262.54279.77303.16371.76464.71555.45679.76
0.2000.30.2000.10.20.10.30.40.80.70.625.629.932.542.545.6149.0349.9354.7858.3866.5570.9283.0291.68101.39
15.213.814.214.814.114.414.515.11820.925.326.829.439.346.12128.839.84337.4335.8840.8140.352.4953.2973.6478.190.6286.36
000000000000000000000000180000
001.72.21.110.70.91.61.40.10.20.72.52.63.33.74.95.421.2420.9429.546.1579.5878.23161.4189.14270.49266.9
0.040.050.050.050.060.060.070.050.080.080.10.110.120.130.160.180.210.230.250.290.320.370.40.470.50.680.811.011.13
002.43.93.22.41.81.71.300.522.112.317.317.61828.259.9105.1488.5159.33112.2361.27427.15491.59501.79601.05755.79
0004.62.21.50.90.40.30.50.50.30.20.50.50.30.30.200000000000
2.732.901.40.41.10.71.11.89.58.67.76.47.17.110.510.112.214.2611.79.517.434.977.7114.4218.115.6813.85
2.735.38.56.84.33.82.82.72.310.510.91019.224.92528.838.572.1119.4100.2268.84119.6666.24434.87506.01519.89616.73769.64
0.040.050.060.060.070.070.070.060.080.080.110.120.130.140.180.20.240.270.320.410.420.440.520.540.941.181.331.621.9
0.090.110.130.140.150.150.160.150.170.180.220.230.260.280.330.380.440.50.60.720.760.820.951.011.462.192.412.773.11
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Dimed SA Distribuidora de Medicamentos provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Dimed SA Distribuidora de Medicamentos's financial health and stability.

Assets

Dimed SA Distribuidora de Medicamentos's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Dimed SA Distribuidora de Medicamentos must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Dimed SA Distribuidora de Medicamentos after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Dimed SA Distribuidora de Medicamentos's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M BRL)DEPRECIATION (M BRL)DEFERRED TAXES (k BRL)CHANGES IN WORKING CAPITAL (k BRL)NON-CASH ITEM (M BRL)PAID INTEREST (M BRL)PAID TAXES (M BRL)NET CASH FLOW FROM OPERATING ACTIVITIES (M BRL)CAPITAL EXPENDITURES (M BRL)CASH FLOW FROM INVESTING ACTIVITIES (M BRL)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M BRL)INTEREST INCOME AND EXPENSES (M BRL)NET DEBT CHANGE (M BRL)NET CHANGE IN EQUITY (M BRL)CASH FLOW FROM FINANCING ACTIVITIES (M BRL)CASH FLOW FROM OTHER FINANCING ACTIVITIES (BRL)TOTAL DIVIDENDS PAID (M BRL)NET CHANGE IN CASH FLOW (M BRL)FREE CASH FLOW (M BRL)SHARE-BASED COMPENSATION (M BRL)
200820092010201120122013201420152016201720182019202020212022
92930516456494553597476567986
6677811141820242895117157184
1,0000000-1,000001,00001,000-10,000-11,000-5,000-12,000
-3,0000-32,000-13,000-57,000-11,000-60,000-7,0001,000-64,000-11,000-55,000-78,000-111,000-108,000
-2326371915252217-50471055
000000000000000
0020000-112221190844
1039850196222721014010955130131205
-12-14-18-26-26-89-55-31-37-43-58-53-84-135-181
-12-14-18-26-26-89-55-31-37-43-58-53-39014-131
000000000000-30515050
000000000000000
8400102953-35-4256-2851-103-181-53
0000000000-140440-19-1
4-3-9-1001738-48-5838-7030318-221-103
--1.00-1.00--------10.00----23.00
-4-6-8-9-10-11-13-12-15-17-17-20-18-20-24
121-1914-8-95-7536-193258-75-28
-2.625-1024.4-7.7-26.9-32.8240.5963.97-2.3650.932.0646.19-4.423.84
000000000000000

Dimed SA Distribuidora de Medicamentos stock margins

The Dimed SA Distribuidora de Medicamentos margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Dimed SA Distribuidora de Medicamentos. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Dimed SA Distribuidora de Medicamentos.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Dimed SA Distribuidora de Medicamentos's sales revenue. A higher gross margin percentage indicates that the Dimed SA Distribuidora de Medicamentos retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Dimed SA Distribuidora de Medicamentos's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Dimed SA Distribuidora de Medicamentos's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Dimed SA Distribuidora de Medicamentos's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Dimed SA Distribuidora de Medicamentos. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Dimed SA Distribuidora de Medicamentos's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Dimed SA Distribuidora de Medicamentos Margin History

Dimed SA Distribuidora de Medicamentos Gross marginDimed SA Distribuidora de Medicamentos Profit marginDimed SA Distribuidora de Medicamentos EBIT marginDimed SA Distribuidora de Medicamentos Profit margin
2028e30.87 %5.05 %0 %
2027e30.87 %0 %0 %
2026e30.87 %4.54 %3.18 %
2025e30.87 %4.07 %2.92 %
2024e30.87 %3.44 %2.47 %
202330.87 %3.63 %2.08 %
202231.14 %3.35 %2.16 %
202130.65 %2.96 %2.46 %
202029.22 %3.12 %1.99 %
201929.69 %4.46 %2.82 %
201829.44 %4.69 %3.08 %
201729.46 %4.12 %2.65 %
201624.44 %5.18 %2.49 %
201522.74 %4.67 %2.28 %
201422.23 %4.68 %2.62 %
201321.95 %4.88 %3.22 %
201222.49 %4.53 %3.09 %
201121.58 %4.24 %2.78 %
201021.53 %4.48 %2.59 %
200921.53 %3.69 %2.76 %
200817.17 %1.09 %1.04 %
200718.46 %2.05 %1.71 %
200618.94 %2.51 %1.96 %
200519.86 %2.29 %1.98 %
200421.45 %2.28 %1.98 %

Dimed SA Distribuidora de Medicamentos Stock Sales Revenue, EBIT, Earnings per Share

The Dimed SA Distribuidora de Medicamentos earnings per share therefore indicates how much revenue Dimed SA Distribuidora de Medicamentos has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Dimed SA Distribuidora de Medicamentos earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Dimed SA Distribuidora de Medicamentos's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Dimed SA Distribuidora de Medicamentos’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Dimed SA Distribuidora de Medicamentos's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Dimed SA Distribuidora de Medicamentos Revenue, EBIT and net profit per share

DateDimed SA Distribuidora de Medicamentos Sales per ShareDimed SA Distribuidora de Medicamentos EBIT per shareDimed SA Distribuidora de Medicamentos Earnings per Share
2028e53.99 BRL0 BRL0 BRL
2027e50.03 BRL0 BRL0 BRL
2026e46.06 BRL0 BRL1.46 BRL
2025e40.92 BRL0 BRL1.19 BRL
2024e36.71 BRL0 BRL0.91 BRL
202329.8 BRL1.08 BRL0.62 BRL
202226.76 BRL0.9 BRL0.58 BRL
202121.56 BRL0.64 BRL0.53 BRL
202018.63 BRL0.58 BRL0.37 BRL
201920.07 BRL0.9 BRL0.57 BRL
201817.85 BRL0.84 BRL0.55 BRL
201716.52 BRL0.68 BRL0.44 BRL
201615.56 BRL0.81 BRL0.39 BRL
201514.52 BRL0.68 BRL0.33 BRL
201413.79 BRL0.65 BRL0.36 BRL
2013378.35 BRL18.48 BRL12.2 BRL
2012331.3 BRL15.02 BRL10.24 BRL
2011292.52 BRL12.41 BRL8.13 BRL
2010258.85 BRL11.59 BRL6.7 BRL
2009233.61 BRL8.63 BRL6.46 BRL
2008202.87 BRL2.22 BRL2.11 BRL
2007181.04 BRL3.72 BRL3.09 BRL
2006156.06 BRL3.91 BRL3.06 BRL
2005137.77 BRL3.15 BRL2.72 BRL
2004123.32 BRL2.81 BRL2.45 BRL

Dimed SA Distribuidora de Medicamentos business model

Dimed SA Distribuidora de Medicamentos is one of the most popular companies on Eulerpool.com.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Dimed SA Distribuidora de Medicamentos Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Dimed SA Distribuidora de Medicamentos historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Dimed SA Distribuidora de Medicamentos shares outstanding

The number of shares was Dimed SA Distribuidora de Medicamentos in 2024 — This indicates how many shares 149.717 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Dimed SA Distribuidora de Medicamentos earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Dimed SA Distribuidora de Medicamentos's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Dimed SA Distribuidora de Medicamentos’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Dimed SA Distribuidora de Medicamentos's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Dimed SA Distribuidora de Medicamentos stock splits

In Dimed SA Distribuidora de Medicamentos's history, there have been no stock splits.

Dimed SA Distribuidora de Medicamentos dividend history and estimates

In 2024, Dimed SA Distribuidora de Medicamentos paid a dividend amounting to 0.34 BRL. Dividend means that Dimed SA Distribuidora de Medicamentos distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Dimed SA Distribuidora de Medicamentos provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Dimed SA Distribuidora de Medicamentos’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Dimed SA Distribuidora de Medicamentos's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Dimed SA Distribuidora de Medicamentos Dividend History

DateDimed SA Distribuidora de Medicamentos Dividend
2028e0.26 BRL
2027e0.26 BRL
2026e0.27 BRL
2025e0.26 BRL
2024e0.26 BRL
20230.25 BRL
20220.28 BRL
20210.13 BRL
20200.02 BRL
20190.09 BRL
20180.07 BRL
20170.02 BRL
20160.04 BRL
20150.04 BRL
20140.04 BRL
20130.05 BRL
20120.04 BRL
20110.05 BRL
20100.05 BRL
20090.06 BRL
20080.03 BRL
20070.03 BRL
20060.03 BRL
20050.03 BRL
20040.04 BRL

Dimed SA Distribuidora de Medicamentos dividend payout ratio

In 2024, Dimed SA Distribuidora de Medicamentos had a payout ratio of 32.94%. The payout ratio indicates the percentage of the company's profits that Dimed SA Distribuidora de Medicamentos distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Dimed SA Distribuidora de Medicamentos represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Dimed SA Distribuidora de Medicamentos could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Dimed SA Distribuidora de Medicamentos's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Dimed SA Distribuidora de Medicamentos Payout Ratio History

DateDimed SA Distribuidora de Medicamentos Payout ratio
2028e33.62 %
2027e33.45 %
2026e31.65 %
2025e35.75 %
2024e32.94 %
202326.25 %
202248.06 %
202124.51 %
20206.19 %
201916.25 %
201813.32 %
20174.02 %
201610.26 %
201512.08 %
201411.36 %
20130.42 %
20120.4 %
20110.63 %
20100.67 %
20090.93 %
20081.5 %
20071.06 %
20061.01 %
20051.03 %
20041.77 %
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Dimed SA Distribuidora de Medicamentos.

Dimed SA Distribuidora de Medicamentos latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
3/31/20190.11 BRL0.11 BRL (-4.43 %)2019 Q1
1

Dimed SA Distribuidora de Medicamentos shareholders

%
Name
Stocks
Change
Date
9.01171 % Mottin Andrighetto (Júlio Ricardo)13,551,81609/5/2024
5.37291 % Kinea Investimentos Ltda.8,079,77609/5/2024
4.06116 % Weber (Roberto Luiz)6,107,16810,0009/5/2024
3.92958 % Weber Otto (Geraldo)5,909,29509/5/2024
3.92073 % Real Investor Gestao de Recursos Ltda.5,896,00031,30010/31/2024
3.85047 % Luce Weber (Martha)5,790,33709/5/2024
3.80274 % Pizzato (Denis)5,718,560-230,1359/5/2024
3.49799 % Pizzato (Regis)5,260,28409/5/2024
3.29139 % SPX Capital4,949,58629,4787/31/2024
3.23477 % Taylor Weber (Elisabeth)4,864,44409/5/2024
1
2
3
4
5
...
10

Most common questions regarding Dimed SA Distribuidora de Medicamentos

What is the P/E ratio of Dimed SA Distribuidora de Medicamentos 2025?

The Dimed SA Distribuidora de Medicamentos P/E ratio is 6.81.

What is the P/S ratio of Dimed SA Distribuidora de Medicamentos 2025?

The Dimed SA Distribuidora de Medicamentos P/S ratio is 0.2.

What is the Quality Investing of Dimed SA Distribuidora de Medicamentos?

The Quality Investing for Dimed SA Distribuidora de Medicamentos is 7/10.

What is the revenue of Dimed SA Distribuidora de Medicamentos 2025?

The expected Dimed SA Distribuidora de Medicamentos revenue is 6.15 B BRL.

How high is the profit of Dimed SA Distribuidora de Medicamentos 2025?

The expected Dimed SA Distribuidora de Medicamentos profit is 179.67 M BRL.

What is the business model of Dimed SA Distribuidora de Medicamentos

No history available for Dimed SA Distribuidora de Medicamentos.

What is the Dimed SA Distribuidora de Medicamentos dividend?

Dimed SA Distribuidora de Medicamentos pays a dividend of 0.28 BRL distributed over payouts per year.

How often does Dimed SA Distribuidora de Medicamentos pay dividends?

The dividend cannot currently be calculated for Dimed SA Distribuidora de Medicamentos or the company does not pay out a dividend.

What is the Dimed SA Distribuidora de Medicamentos ISIN?

The ISIN of Dimed SA Distribuidora de Medicamentos is BRPNVLACNOR9.

What is the Dimed SA Distribuidora de Medicamentos ticker?

The ticker of Dimed SA Distribuidora de Medicamentos is PNVL3.SA.

How much dividend does Dimed SA Distribuidora de Medicamentos pay?

Over the past 12 months, Dimed SA Distribuidora de Medicamentos paid a dividend of 0.25 BRL . This corresponds to a dividend yield of about 3.08 %. For the coming 12 months, Dimed SA Distribuidora de Medicamentos is expected to pay a dividend of 0.27 BRL.

What is the dividend yield of Dimed SA Distribuidora de Medicamentos?

The current dividend yield of Dimed SA Distribuidora de Medicamentos is 3.08 %.

When does Dimed SA Distribuidora de Medicamentos pay dividends?

Dimed SA Distribuidora de Medicamentos pays a quarterly dividend. This is distributed in the months of May, July, November, January.

How secure is the dividend of Dimed SA Distribuidora de Medicamentos?

Dimed SA Distribuidora de Medicamentos paid dividends every year for the past 0 years.

What is the dividend of Dimed SA Distribuidora de Medicamentos?

For the upcoming 12 months, dividends amounting to 0.27 BRL are expected. This corresponds to a dividend yield of 3.24 %.

In which sector is Dimed SA Distribuidora de Medicamentos located?

Dimed SA Distribuidora de Medicamentos is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Dimed SA Distribuidora de Medicamentos kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Dimed SA Distribuidora de Medicamentos from 3/31/2026 amounting to 0.095 BRL, you needed to have the stock in your portfolio before the ex-date on 12/17/2024.

When did Dimed SA Distribuidora de Medicamentos pay the last dividend?

The last dividend was paid out on 3/31/2026.

What was the dividend of Dimed SA Distribuidora de Medicamentos in the year 2024?

In the year 2024, Dimed SA Distribuidora de Medicamentos distributed 0.252 BRL as dividends.

In which currency does Dimed SA Distribuidora de Medicamentos pay out the dividend?

The dividends of Dimed SA Distribuidora de Medicamentos are distributed in BRL.

All fundamentals about Dimed SA Distribuidora de Medicamentos

Our stock analysis for Dimed SA Distribuidora de Medicamentos Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Dimed SA Distribuidora de Medicamentos Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.